Dresner Partners Advised RADfertility in Its Sale to CCRM Fertility
CHICAGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised RADfertility in its sale to CCRM Fertility.
- CHICAGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised RADfertility in its sale to CCRM Fertility.
- CCRM Fertility is a global pioneer in fertility treatment, research and science.
- The synergies between the two organizations will further enhance and expand the reach of the CCRM network.”
Steven M. Dresner, President of Dresner Partners added, “We are very pleased that we were able to help RADfertility find a strategic partner in CCRM Fertility. - There is tremendous opportunity for providers to combine their resources to meet their long-term growth objectives.”
Dresner Partners is a leading provider of investment banking services to the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA NJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, the sale of Santa Monica Fertility to Webster Equity Partners, the sale of In Via Fertility to InVitro Sciences (now First Fertility), the sale of Institute for Human Reproduction to Pinnacle Fertility, the sale of Dominion Fertility to Pinnacle Fertility, the sale of Center of Reproductive Medicine to US Fertility, the sale of IVF1 to Pinnacle Fertility, the sale of Fertility Institute of New Jersey & New York to Axia Women’s Health, and the sale of RADfertility to CCRM Fertility.